Watchdog group cautious on Amylyx's ALS drug benefits, potential cost | BioPharma Dive

Retrieved on: 2022-06-14 15:56:02

Tags for this article:

Click the tags to see associated articles and topics

Watchdog group cautious on Amylyx's ALS drug benefits, potential cost | BioPharma Dive. View article details on hiswai:

Excerpt

Amylyx Pharmaceuticals' experimental ALS drug would “far exceed” common cost-effectiveness measures if the company prices it on par with another ...

Article found on: www.biopharmadive.com